When journalist Jon Gluck learned he had multiple myeloma, doctors told him he had 18 months to live. That was 20 years ago. ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

Eight men were arrested in Delhi for a racket selling counterfeit anti-cancer drugs. The operation, led by Naveen Arya, ...

At the crossroads of innovation and equity, Josette Gbemudu and Merck are helping rewrite the narrative for breast cancer ...

LIC’s shareholding in Dr. Reddy’s Laboratories rose from 5.6% at the end of September 2024 to 6.5% by December 2024, and ...

Dr. Reddy’s Laboratories has partnered with global biotech firm Alvotech to co-develop and commercialize a biosimilar of ...

Alvotech and Dr. Reddy's will co-develop a biosimilar to Keytruda, aiming to expand global access to cancer treatment alternatives.

Vividion Therapeutics secures worldwide rights to develop & commercialize clinical-stage WRN covalent inhibitor, VVD-214: San Diego, California Friday, June 6, 2025, 11:00 Hrs [IS ...

Erasing losses, the BSE Sensex on Friday rallied 755.37 pts at 82,197.37 till noon trade, after the RBI announced a rate cut ...

The BSE Sensex on Friday fell by 113.65 pts to 81,328.39 in early trade tracking negative cues from Asian peers.

Sanofi picked up Blueprint Medicines in a deal worth up to $9.5 billion. Bristol Myers Squibb will pay $1.5 billion upfront ...

Fengting Yan, MD, PhD, discusses unmet needs in breast cancer care and issues for specific subgroups of patients.